- Home
- BNR vs VTVT Comparison
BNR vs VTVT Comparison
Compare BNR & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- VTVT
- Stock Information
- Founded
- BNR 2014
- VTVT 2015
- Country
- BNR China
- VTVT United States
- Employees
- BNR N/A
- VTVT N/A
- Industry
- BNR Medical Specialities
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- VTVT Health Care
- Exchange
- BNR Nasdaq
- VTVT Nasdaq
- Market Cap
- BNR 38.3M
- VTVT 45.8M
- IPO Year
- BNR 2020
- VTVT 2015
- Fundamental
- Price
- BNR $4.68
- VTVT $16.77
- Analyst Decision
- BNR
- VTVT Strong Buy
- Analyst Count
- BNR 0
- VTVT 2
- Target Price
- BNR N/A
- VTVT $35.50
- AVG Volume (30 Days)
- BNR 17.3K
- VTVT 9.1K
- Earning Date
- BNR 08-21-2025
- VTVT 08-07-2025
- Dividend Yield
- BNR N/A
- VTVT N/A
- EPS Growth
- BNR N/A
- VTVT N/A
- EPS
- BNR N/A
- VTVT N/A
- Revenue
- BNR $72,112,038.00
- VTVT $17,000.00
- Revenue This Year
- BNR $136.32
- VTVT N/A
- Revenue Next Year
- BNR N/A
- VTVT N/A
- P/E Ratio
- BNR N/A
- VTVT N/A
- Revenue Growth
- BNR 0.53
- VTVT N/A
- 52 Week Low
- BNR $2.18
- VTVT $12.12
- 52 Week High
- BNR $7.90
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- BNR 69.57
- VTVT 52.80
- Support Level
- BNR $4.47
- VTVT $16.16
- Resistance Level
- BNR $4.96
- VTVT $17.46
- Average True Range (ATR)
- BNR 0.25
- VTVT 0.64
- MACD
- BNR 0.11
- VTVT 0.22
- Stochastic Oscillator
- BNR 84.31
- VTVT 65.31
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.